SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001558370-24-005582
Filing Date
2024-04-24
Accepted
2024-04-24 16:05:45
Documents
19
Period of Report
2024-06-06

Document Format Files

Seq Description Document Type Size
1 DEF 14A gbio-20240606xdef14a.htm   iXBRL DEF 14A 1356341
2 GRAPHIC gbio-20240606xdef14a_a003.jpg GRAPHIC 6777
3 GRAPHIC gbio-20240606xdef14a_a016.jpg GRAPHIC 51760
4 GRAPHIC gbio-20240606xdef14a_bg001.jpg GRAPHIC 120804
5 GRAPHIC gbio-20240606xdef14a_bg002.jpg GRAPHIC 119357
  Complete submission text file 0001558370-24-005582.txt   2945635

Data Files

Seq Description Document Type Size
6 EX-101.SCH gbio-20240606.xsd EX-101.SCH 6859
7 EX-101.DEF gbio-20240606_def.xml EX-101.DEF 6182
8 EX-101.LAB gbio-20240606_lab.xml EX-101.LAB 21008
9 EX-101.PRE gbio-20240606_pre.xml EX-101.PRE 11846
22 EXTRACTED XBRL INSTANCE DOCUMENT gbio-20240606xdef14a_htm.xml XML 185426
Mailing Address 301 BINNEY STREET CAMBRIDGE MA 02142
Business Address 301 BINNEY STREET CAMBRIDGE MA 02142 857-529-5908
Generation Bio Co. (Filer) CIK: 0001733294 (see all company filings)

IRS No.: 814301281 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-39319 | Film No.: 24870558
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)